Strive Pharmacy
Strive Pharmacy LLC · Gilbert, AZ · operating since 2017
We do not sell medication and we have no commercial relationship with Strive Pharmacy. Everything below is either published by a regulator or published by the pharmacy about itself, labelled as such and dated. We give you the official lookups rather than asking you to take our word for the current position.
The short answer
- Strive Pharmacy is the trading name of Strive Pharmacy LLC, based in Gilbert, AZ. Regulators file under the legal name, so search that.
- Registration: 503A. Strive calls itself a licensed 503A pharmacy on its own site. It is not a registered 503B outsourcing facility, so its compounding is patient-specific and its primary regulator is the Arizona State Board of Pharmacy rather than FDA. It says it is licensed in every state where it ships, and it is one of the larger compounders supplying telehealth platforms.
- AZ licence Y007406: status "Active", discipline on file as of July 29, 2026.
- No FDA warning letter naming Strive Pharmacy LLC surfaced in our check on July 29, 2026 — but there are 3 other public records below, dated February 2024, September 4, 2025, December 2, 2025. A clean FDA record is not the same as a clean record.
- Compounded semaglutide and tirzepatide are NOT FDA-approved as finished products, whichever pharmacy prepares them. FDA does not review them for safety, effectiveness or manufacturing quality.
Registration and licence
Strive calls itself a licensed 503A pharmacy on its own site. It is not a registered 503B outsourcing facility, so its compounding is patient-specific and its primary regulator is the Arizona State Board of Pharmacy rather than FDA. It says it is licensed in every state where it ships, and it is one of the larger compounders supplying telehealth platforms.
- Licence number
- Y007406
- Status
- Active
- Qualifications
- Independent Pharmacy permit (Arizona)
- Discipline on file
- Yes
Accreditation the pharmacy claims
- NABP, PCAB and LegitScript — stated by Strive on its own site, and described there as voluntary
We report this as the pharmacy's own statement. We have not independently confirmed it, and we are not endorsing it.
State board record
Every item below is a public document, linked to its source, with the date it was issued and the dates of any inspection behind it. Where the agency recorded the company's response, a completed recall, or which legal entity a record actually concerns, that is included — leaving it out would misrepresent the record. Where the company has answered publicly, its answer is printed too.
- State board of pharmacyArizona State Board of Pharmacy, Complaint Review Committee
The committee voted to advance two complaints investigated by board staff: one alleging that Strive compounded and tested ketamine patches on an employee, and one alleging that it supplied prescription medication to a clinic that was selling it over the counter rather than dispensing to named patients.
Which entity this concerns: These are ALLEGATIONS advanced to the next stage of a board process. They are not findings, and nothing here says they are true. We record them because the proceedings are public and dated, and we would be leaving out material a reader is entitled to weigh.
The company's response: Strive told the board it stopped dispensing to the clinic within 30 days of being alerted, that its compliance department has grown and its policies have changed in the year since, and that it is not under investigation by the Arizona Attorney General.
Our check on July 29, 2026 did not surface a published close-out. That means we did not find one, not that none exists.
Read the reporting on sherwood.news - State board of pharmacyArizona State Board of Pharmacy inspection
The inspection report records that Strive continued to compound and dispense single-ingredient semaglutide and tirzepatide after the federal shortage-exemption period ended earlier in 2025. The inspector wrote that the pharmacy produced "large amounts of odd strengths/doses in anticipation of prescriptions", and that prescriptions from different providers carried identical wording justifying the compounding of what the report described as essentially copies of commercially available FDA-approved GLP-1 drugs.
Which entity this concerns: An inspection report records what an inspector observed. It is not a disciplinary finding, and no discipline arising from it had been published when we checked.
The company's response: Strive has said it "respectfully disagrees with that characterization of Strive’s GLP-1 compounding activities in the September 4, 2025 inspection report and does not believe it accurately reflects Strive’s compliance with applicable guidance and compounding law."
Our check on July 29, 2026 did not surface a published close-out. That means we did not find one, not that none exists.
Read the reporting on sherwood.news - State board of pharmacyArizona State Board of Pharmacy, Board Case No. 22-0668 — consent agreement
A signed consent agreement between Strive Pharmacy and the Arizona State Board of Pharmacy, entered as the final disposition of the case. The board recorded that Strive began compounding injectable semaglutide in August 2021, roughly seven months before semaglutide was added to the FDA drug-shortage list. Strive agreed to a $1,000 fine.
Which entity this concerns: This is a state board matter, not an FDA action. A consent agreement is a negotiated settlement, not a contested finding.
The company's response: Strive has said publicly that the board did not discipline it over the original allegation of compounding a commercially available product, and that the agreement addressed a documentation issue identified during the inspection.
Our check on July 29, 2026 did not surface a published close-out. That means we did not find one, not that none exists.
Read it on documentcloud.org
What it compounds for GLP-1 patients
- · Compounded semaglutide
- · Compounded tirzepatide
Compounded semaglutide and tirzepatide are not FDA-approved as finished drug products. FDA does not review them for safety, effectiveness or manufacturing quality before they reach patients. That applies to every compounded GLP-1 regardless of which pharmacy prepares it, and it is a separate question from whether the pharmacy is licensed.
If you would rather not take that trade, the FDA-approved oral products now start at $149/month direct from their manufacturers — see the cheapest routes compared.
Check it yourself
Search under the legal name — Strive Pharmacy LLC — not the brand. Regulators file under the legal entity, and searching the trading name alone is how records get missed.
- FDA — Registered Outsourcing Facilities (503B)
The authoritative list of pharmacies registered with the FDA as 503B outsourcing facilities (the higher-oversight compounding tier). If a pharmacy claims to be 503B, it should appear here.
- FDA — 503A vs 503B explainer
What the two compounding categories mean: 503A = patient-specific prescriptions under state board oversight; 503B = larger-batch outsourcing facilities under direct FDA cGMP inspection.
- FDA — Warning Letters search
Search the FDA’s public warning-letter database by company name to see whether a pharmacy has an open compliance action. Confirm the date and status — letters can be resolved.
- NABP — Verify a pharmacy / .pharmacy
The National Association of Boards of Pharmacy tools flag rogue online pharmacies and list accredited ones. Legitimate US pharmacies are licensed by a state board.
- LegitScript — Certification lookup
LegitScript certifies healthcare merchants that meet legal + safety standards. Many reputable telehealth GLP-1 providers display a LegitScript badge you can verify here.
- Your state Board of Pharmacy
Every US pharmacy must be licensed by the state board where it operates (and often where it ships). State boards publish license status + disciplinary history.
Questions people ask about Strive Pharmacy
Is Strive Pharmacy a licensed pharmacy?
The AZ board of pharmacy lists licence Y007406 with status "Active", carrying the Independent Pharmacy permit (Arizona) qualification. The board record shows discipline on file. Licence status changes, so confirm it yourself at the board's lookup before relying on it. Verified July 29, 2026.
What is the regulatory record for Strive Pharmacy?
Our check on July 29, 2026 found no FDA warning letter naming Strive Pharmacy LLC. That does not mean the record is empty: 3 other public documents appear above, dated February 2024, September 4, 2025, December 2, 2025, including state board of pharmacy proceedings. Read them with the company's responses, which are printed alongside.
Does Strive Pharmacy make FDA-approved GLP-1 medication?
No compounding pharmacy does. Strive Pharmacy publicly compounds compounded semaglutide and compounded tirzepatide. Compounded drugs are not FDA-approved: the agency does not review them for safety, effectiveness or manufacturing quality before they reach patients. That is true of every compounded product regardless of which pharmacy prepares it, and it is a different thing from the pharmacy being licensed or unlicensed.
How do I check Strive Pharmacy myself?
Three free lookups settle it: the FDA warning-letter database, searched by the legal name (Strive Pharmacy LLC) rather than the trading name; the FDA list of registered 503B outsourcing facilities, if the pharmacy claims 503B status; and your state board of pharmacy's licence verification. All three are linked at the bottom of this page. Check the legal name — regulators file under it, and searching the brand alone misses records.